Looking for a Washington, DC Enbrel attorney? Get in touch with one of our Washington, DC Enbrel attorneys now.
Home : Unsafe Drugs : Enbrel : MSN Newsfeeds
Enbrel - MSN Newsfeeds
- NewsMax.com - Patients with severe psoriasis previously treated with Enbrel (also known as etanercept) may respond to Remicade (also known as infliximab), a study published this month suggests. Remicade, which is given by intravenous infusion and is used to treat ...
- MSN MoneyCentral - Lehman Brothers analyst Dr. Jim Birchenough expects sales of Amgen Inc.'s drugs Neulasta and Enbrel to fall short of Wall Street expectations and is unsure whether Aranesp and Epogen will match projections. Meanwhile, Credit Suisse initiated coverage ...
- Seattle Post Intelligencer - She started taking a biologic called Enbrel several years ago and recently said she now makes plans without worrying if she'll be in a wheelchair. Biologics have been a godsend for patients with a range of ailments, from cancer and neurological ...
- WAFF - TUESDAY, June 19 (HealthDay News) -- Patients who used the psoriasis drug Enbrel for more than a year had no more adverse effects than patients taking a placebo, a new study found. And most patients showed an improvement in their psoriasis, according ...
- HealthScout - Enbrel (etanercept) is a drug that blocks tumor necrosis factor, a pro-inflammatory cytokine. People with an immune disease, such as psoriasis, have too much tumor necrosis factor (TNF) in their bodies. Enbrel reduces the amount of TNF to normal levels ...
- HealthScout - Enbrel) is already FDA-approved to treat psoriasis and is a systemic, biologic medication that affects the entire body. In this study, researchers simply wanted to determine the long-term effects of using the drug. Authors of the study write, "We ...
- SAWF News Connect - An extended study of the longest continuous exposure of patients with psoriasis to 50 milligrams of etanercept biweekly provides further insights into the safety and efficacy of high-dose etanercept therapy for the management of moderate to severe ...
- News-Medical.Net - JRA is a chronic autoimmune disease of childhood that is sometimes difficult to diagnose. ENBREL is the only biologic medicine currently approved to treat the signs and symptoms of JRA in patients who have previously tried a traditional disease ...
- HealthCentral.com - NEW YORK (Reuters Health) - The symptoms of moderate-to-severe psoriasis are improved by treatment with Enbrel, known generically as etanercept, and the therapy remains safe and effective for up to 96 weeks, according to a new study The Canadian and ...
- Medical News Today - Before receiving treatment with ORENCIA individuals should tell their doctor if they are taking a TNF blocker (e.g., Enbrel®, Humira®, Remicade®) to treat rheumatoid arthritis (RA). ORENCIA® (abatacept) should not be taken with these medications ...
- EurekAlert - THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., June 13, 2007 -- Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced the presentation of additional data that showed that the safety profile of Enbrel ...
- Phramalive.com - in San Francisco. The judges, who selected the winners from more than 800 entries from 160 companies in the U.S. and Canada, chose Glow Worm’s “Step-by-Step Guide to Taking Enbrel” as one of the year's best medical marketing pieces. Awards were ...
- PR Newswire - Barbara's clinical expertise in autoimmune and inflammatory diseases and her proven track record bringing drugs to market - including the blockbuster drug Enbrel(R) - will serve Osprey well as we move our rich pipeline of product candidates forward ...
- Akron Beacon Journal - ... IV prostate cancer. • Research into the ability of the elderly to fight infection when the immune response is triggered by injury. • Radiation therapy in treating patients with brain and central nervous system tumors. • A study of the drug Enbrel ...
- Wall Street Journal - Competitors to Humira for certain diseases include Johnson & Johnson's Remicade and the drug Enbrel, which is co-marketed by Amgen Inc. and Wyeth . Also, Belgian pharmaceutical company UCB SA is targeting its drug Cimzia at multiple diseases. Remicade is ...
- Providence Journal - Sales of the company’s drug Enbrel, manufactured in West Greenwich, remain strong. But questions have been raised about Amgen’s blockbuster anemia drugs, Aranesp and Epogen, sending the company’s stock tumbling. Amgen’s net income last year ...
- Free Lance-Star - They include: AstraZeneca's being told by the FDA to "immediately cease" its ads for Crestor because of "misleading" claims. Biotech company Amgen's being told to stop running an ad that "minimizes the risks" associated with its product Enbrel.
- Harvard Crimson - Research in his lab led to the development of Enbrel, a rheumatoid arthritis drug. His hospital, Mass. General, has sold rights to the discovery and earned $400 million for itself. Seed’s own cut from the contracts: $133 million. —Staff writer ...
- Medical News Today - The PASI-90 response of 14% for CC-10004 is comparable to Enbrel dosed at 25 mg twice weekly." Based on these results, Celgene is accelerating clinical and regulatory strategies for CC-10004 in psoriasis, psoriatic arthritis, rheumatoid ...
- HealthCentral.com - Does the superiority of Enbrel or Remicade or Humira justify their significantly higher costs? And if so, who should pay for these drugs? If there are limited dollars for health care, do we spend the money to pay for these newer rheumatoid ...
Looking for a Washington, DC Enbrel attorney? Get in touch with one of our Washington, DC Enbrel attorneys now.
Pages: 1 2 3 4 5 6 ... Next
